Ansa Biotechnologies
Next-generation DNA synthesis using enzymes
Dan Lin-Arlow, Sebastian Palluk · 2 co-founders
2024Funding round
Team
72
current
Co-founders
2
current
Stage
Round
Round
$46M
Revenue · $2M · startupintros.com
Source for Funding round
Profile coverage5 of 8 · missing Signals, Customers, Stack / tools · last run 8/10/2026
About
Ansa Biotechnologies is developing a new way to make DNA that will be faster, cleaner, and more accurate than existing methods. Currently, DNA is manufactured via a chemical method that has remained mostly unchanged for 35 years. Our enzyme-based approach promises to dramatically accelerate innovation in biological research and biotechnology, including therapeutics, diagnostics and biomanufacturing.